Most applications target CNS tumors, demyelinating disorders, inflammatory neuropathies or CNS infection. Applications reviewed by CNBT propose levels of investigation combining cellular-molecular in vitro studies with animal models, and ranging from mechanistic to biomarker and imaging studies in human patients.

 

The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Membership Panel

The membership panel is a list of chartered members only.

Topics


  • CNS autoimmune demyelination diseases including multiple sclerosis (MS), its animal model experimental autoimmune encephalomyelitis (EAE), and myasthenia gravis;
  • Primary brain tumors including glioma, glioblastoma, medulloblastomas
  • CNS infectious diseases including viral infections, bacterial infections, or parasite infections.
  • Neuroinflammation in brain degenerative diseases including Alzheimer’s disease, Parkinson’s disease, etc.
  • Neuroimmune processes: cellular and humoral immune responses, immune cells, cytokines/chemokines, innate immunity, autoimmunity, and neuroimmune modulation.
  • Pathophysiology: Demyelination/remyelination, neuroinflammation, axonal damage and repair, microglia and astrocyte activation, macrophages, tumorigenesis, tumor migration, invasion, angiogenesis, tumor microenvironment
  • Genetic and gender susceptibility in neuroimmune diseases
  • The role and physiopathology of blood brain barrier and brain vasculature in neuroinflammation, trafficking of immune cells, viral gene therapy, cell transplantation, and vascular damage and permeability.
  • Identification of potential therapeutic targets for the above relevant diseases, including immunotherapy, gene therapy, and small molecules

Shared Interests and Overlaps

There are shared interests with Hypersensitivity, Autoimmune, and Immune-mediated Diseases (HAI). Applications primarily focused on the biology of the innate and adaptive immune systems in CNS are reviewed in HAI vs. the focus on role of the innate and adaptive immune systems in the pathogenesis the CNS autoimmune demyelination diseases CNBT.

Applications focusing on the basic science and mechanistic studies involving immunological processes in neural diseases may also be assigned to Cellular Molecular Biology of Glia (CMBG). These include demyelinating diseases, inflammatory neuropathies, neurodegenerative disorders, nervous system tumors. Studies on the role of glia and blood-brain barrier in the mechanisms underlying these diseases can also be reviewed by CMBG. In comparison, applications focusing on the pathogenesis, progression, and treatment of CNS autoimmune demyelinating diseases and primary brain tumors are assigned to CNBT.

Applications focusing on the pathogenesis, mechanisms, structural and functional alteration, as well as the treatment of different CNS degenerative diseases are assigned to Chronic Dysfunction and Integrative Neurodegeneration (CDIN). Applications focusing on the neuroimmunology and neuroinflammation in these CNS degenerative diseases can be reviewed by CNBT. with regard to neurodegenerative diseases (e.g., AD) – focus on the diseases CDIN vs. focus on neuroimmune cells and pathways CNBT.

There are shared interests with Cancer Immunopathology and Immunotherapy (CII) and TME for applications focused on the immunologic treatment of CNS cancer cells or the cancer cells interactions with their microenvironment, respectively.

There are shared interests with Virology A (VIRA) and Virology B (VIRB). Applications addressing fundamental aspects of non-HIV and non-bacteriophage viral genetics, infection and replication may be assigned to VIRA or VIRB vs. CNS infectious diseases from viral infections CNBT. ​